Aneurysm, Ruptured: Clinical Trials

3 trials for Aneurysm, Ruptured, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated, 1 unknown. 3 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 1, Terminated 1, Unknown 1
Phase 22Completed 1, Unknown 1

Follow Aneurysm, Ruptured: new trials by email Literature Review of Aneurysm, Ruptured trials Research Report on Aneurysm, Ruptured

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Neuroprotective Effect of Remote Ischemic Conditioning in Ruptured Aneurysm Coiling Therapy
remote ischemic conditioning, sham remote ischemic conditioning - Aneurysm, Ruptured, Coiling Therapy
Phase 2 / Phase 3UnknownCapital Medical University2102018-10-062018-11-23
Study of EG-1962 Compared to Standard of Care Oral Nimodipine in Adults With Aneurysmal Subarachnoid Hemorrhage
EG-1962 (nimodipine microparticles), Enteral Nimodipine - Subarachnoid Hemorrhage, Aneurysmal
Phase 3TerminatedEdge Therapeutics Inc3742016-07-012018-07-26
Clinical Efficacy of In-situ Thrombolysis in Case of Intraventricular Haemorraghia by Aneurysm Rupture
fibrinolysis in situ, drainage - Aneurysm, Ruptured, Subarachnoid Hemorrhage
Phase 2 / Phase 3CompletedCentre Hospitalier Universitaire de Nice192005-10-012026-03-31

Narrower conditions

Subarachnoid Hemorrhage (2)

Broader conditions

Aneurysm (3)  ·  Cardiovascular Diseases (3)  ·  Vascular Diseases (3)  ·  Brain Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Cerebrovascular Disorders (2)  ·  Hemorrhage (2)  ·  Intracranial Hemorrhages (2)  ·  Nervous System Diseases (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)

Interventions

Drainage (1)  ·  EG-1962 (1)  ·  Fibrinolysis (1)

Sponsors

Capital Medical University (1)  ·  Centre Hospitalier Universitaire de Nice (1)  ·  Edge Therapeutics Inc (1)

Countries

Australia (1)  ·  Austria (1)  ·  Canada (1)  ·  China (1)  ·  Czechia (1)  ·  Finland (1)  ·  France (1)  ·  Germany (1)  ·  Hong Kong (1)  ·  Israel (1)  ·  New Zealand (1)  ·  Singapore (1)  ·  United States (1)

Top investigators

R. Loch Macdonald, MD, PhD (1)

Results publications

PMID 23636409, PMID 30014184, PMID 32138631